Risk Factors for the Adverse Events after Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplantation Patients

Despite the therapeutic equivalence between twice-daily and once-daily tacrolimus, patient safety after conversion is still a concern. We reviewed 218 liver transplantation (LT) patients who converted twice-daily to once-daily tacrolimus between May 2011 and January 2014. Thirty (13.8%) patients had...

Descripción completa

Detalles Bibliográficos
Autores principales: Suh, Suk-Won, Lee, Kwang-Woong, Jeong, Jaehong, Kim, Hyeyoung, Yi, Nam-Joon, Suh, Kyung-Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056201/
https://www.ncbi.nlm.nih.gov/pubmed/27709847
http://dx.doi.org/10.3346/jkms.2016.31.11.1711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056201/
https://www.ncbi.nlm.nih.gov/pubmed/27709847
http://dx.doi.org/10.3346/jkms.2016.31.11.1711

Ejemplares similares